Phillip A. Low

Neurology

5716 Cleveland St Ste 200
Virginia Beach, VA 23462

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 144 publications

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

Journal: The Lancet. Infectious diseases

Published: April 05, 2026

Developing a platform protocol for clinical trials evaluating interventions that target proposed mechanisms of Long COVID: RECOVER-VITAL.

Developing a platform protocol for clinical trials evaluating interventions that target proposed mechanisms of Long COVID: RECOVER-VITAL.

Journal: Clinical trials (London, England)

Published: March 06, 2026

Precise disease heterogeneity and progression quantification in MSA and Parkinson's disease using machine learning.

Precise disease heterogeneity and progression quantification in MSA and Parkinson's disease using machine learning.

Journal: Scientific reports

Published: December 09, 2025

Harlequin syndrome: using clinical features and autonomic testing to unmask the disorder.

Harlequin syndrome: using clinical features and autonomic testing to unmask the disorder.

Journal: Clinical autonomic research : official journal of the Clinical Autonomic Research Society

Published: December 12, 2024

The phenotype of "pure" autonomic failure.

The phenotype of "pure" autonomic failure.

Journal: Clinical autonomic research : official journal of the Clinical Autonomic Research Society

Published: December 12, 2024

Accuracy of chat-based artificial intelligence for patient education on orthostatic hypotension.

Accuracy of chat-based artificial intelligence for patient education on orthostatic hypotension.

Journal: Clinical autonomic research : official journal of the Clinical Autonomic Research Society

Published: November 20, 2024

Clinical and Laboratory Features Predict Phenoconversion from Sporadic Adult-onset Ataxia to Multiple System Atrophy.

Clinical and Laboratory Features Predict Phenoconversion from Sporadic Adult-onset Ataxia to Multiple System Atrophy.

Journal: Cerebellum (London, England)

Published: November 11, 2024

Blood-Based Nanoparticle-Enhanced Quaking-Induced Conversion (Nano-QuIC): Inhibitor-Resistant Detection of Seeding Activity in Patients Diagnosed with Parkinson's Disease.

Blood-Based Nanoparticle-Enhanced Quaking-Induced Conversion (Nano-QuIC): Inhibitor-Resistant Detection of Seeding Activity in Patients Diagnosed with Parkinson's Disease.

Journal: Nano letters

Published: November 01, 2024

Autonomic impairment in primary lateral sclerosis.

Autonomic impairment in primary lateral sclerosis.

Journal: Clinical autonomic research : official journal of the Clinical Autonomic Research Society

Published: February 29, 2024

White Matter Abnormalities Track Disease Progression in Multiple System Atrophy.

White Matter Abnormalities Track Disease Progression in Multiple System Atrophy.

Journal: Movement disorders clinical practice

Published: December 27, 2023

Neurofilament Light Chain in Spinal Fluid and Plasma in Multiple System Atrophy - A Prospective, Longitudinal Biomarker Study.

Neurofilament Light Chain in Spinal Fluid and Plasma in Multiple System Atrophy - A Prospective, Longitudinal Biomarker Study.

Journal: Research square

Published: August 14, 2023

Neurofilament light chain in spinal fluid and plasma in multiple system atrophy: a prospective, longitudinal biomarker study.

Neurofilament light chain in spinal fluid and plasma in multiple system atrophy: a prospective, longitudinal biomarker study.

Journal: Clinical autonomic research : official journal of the Clinical Autonomic Research Society

Published: July 25, 2023

Showing 1-12 of 144

Last Updated: 09/26/2026